Elutia vs Nexgel
Elutia reported revenue of $12 million in fiscal 2025, about the same as Nexgel's $11 million in fiscal 2025. Elutia's revenue fell 15.0% in its latest year, and Nexgel's grew 31.5%. Elutia had an operating margin of -218.9%, against -29.4% at Nexgel. Free cash flow was −$47 million at Elutia and −$1 million at Nexgel.
Side by side
| Elutia | Nexgel | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $12M | $11M |
| Revenue growth | −15.0% | 31.5% |
| Revenue growth a year, last 5 years | −22.0% | 74.7% |
| Gross margin | 53.7% | 39.5% |
| Operating margin | −218.9% | −29.4% |
| Net margin | 434.2% | −26.3% |
| Free cash flow | −$47M | −$1M |
| Free cash flow margin | −379.8% | −12.1% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 58.0% | 20.6% |
| Last close | $0.81 | $3.35 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $215,115, sold $0 | — |
| Piotroski F-score | — | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
ElutiaNexgel
Operating margin
Percent of revenue
ElutiaNexgel
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ElutiaNexgel